Back to search

University of Denver

The Case for Extending Patent Terms for Drugs That Treat Rare Diseases

Abstract

dc:description.abstract

This paper seeks to determine if extended patent terms can positively effect the production of drugs that treat rare diseases. It reviews the structure of the modern pharmaceutical company and considers the regulatory history that lead to this structure. The paper applies historically significant economic research in the field of patents and considers patent alternatives to establish the best method for incentivizing the development of these drugs. The paper finds that while there are numerous pitfalls and issues with the patent method, there are no viable alternatives. It also concludes that extending patent terms for drugs that treat rare diseases can act as a catalyst to orphan drug development.

Degree

thesis:*
Name thesis:degree_name
M.A.
Level thesis:degree_level
Masters Thesis

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Thompson, Joanna Louise
Contributors dc:contributor
  • Peter Ho, Ph.D.
  • Markus Schneider
  • Yavuz Yasar

Subjects

dc:subject × 5

Rights

dc:rights
Statement dc:rights
  • <p>Copyright is held by the author. User is responsible for all copyright compliance.</p>
  • Joanna Louise Thompson
Language dc:language
en

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.du.edu/etd/648

Chain of custody

source
Harvested from
University of Denver
Base URL
digitalcommons.du.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Thompson, Joanna Louise. The Case for Extending Patent Terms for Drugs That Treat Rare Diseases. Masters Thesis thesis, https://digitalcommons.du.edu/etd/648